rs202004044
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP6BS2
The NM_006922.4(SCN3A):c.1687C>T(p.Arg563Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000193 in 1,613,652 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R563H) has been classified as Likely benign.
Frequency
Consequence
NM_006922.4 missense
Scores
Clinical Significance
Conservation
Publications
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: DEFINITIVE Submitted by: Illumina, ClinGen
- developmental and epileptic encephalopathy, 62Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- epilepsy, familial focal, with variable foci 4Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152056Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000200 AC: 50AN: 249778 AF XY: 0.000230 show subpopulations
GnomAD4 exome AF: 0.000197 AC: 288AN: 1461596Hom.: 1 Cov.: 31 AF XY: 0.000205 AC XY: 149AN XY: 727098 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000158 AC: 24AN: 152056Hom.: 0 Cov.: 32 AF XY: 0.000189 AC XY: 14AN XY: 74254 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
- -
SCN3A: PP2, PP3, BS2 -
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
not specified Benign:1
- -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at